CLINICAL_TRIALS
trial_result
· 2012-10-08
Clinical Trial Update: An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia [Phase 3]
Summary
This clinical trial update reports on a Phase 3 open-label multicenter study evaluating the dose distribution of Paliperidone ER in patients with schizophrenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen-Cilag Pty Ltd | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2012-10-08